Published online Aug 27, 2022. doi: 10.4240/wjgs.v14.i8.799
Peer-review started: February 14, 2022
First decision: April 5, 2022
Revised: May 8, 2022
Accepted: July 31, 2022
Article in press: July 31, 2022
Published online: August 27, 2022
Processing time: 191 Days and 0 Hours
Endoscopic treatment of pancreatic necrosis can be challenging and time consuming because sticky necrotic debris is sometimes difficult to remove. The over-the-scope-grasper, a new tool that has recently become available for this purpose, might also be useful for other indications.
To evaluate the technical success and safety of the new over-the-scope-grasper in a multicenter setting.
We retrospectively evaluated the use of the over-the-scope-grasper in nine selected endoscopic centers and aimed to investigate the technical success and safety of device use.
We retrospectively evaluated 56 procedures performed between November 2020 and October 2021. In addition to technical success and complications, we evaluated procedural parameters such as the indications, duration of the procedure, type of sedation, and, in the case of pancreatic necrosectomy, the access route, stent type, and number of pieces of necrosis removed.
The overall technical success rate was 98%. The technical success of pancreatic necrosectomy (37 cases) was 97%, with a mean of eight pieces of necrosis removed in a mean of 59 min. In addition, the device has been used to remove blood clots (n = 6) to clear insufficiency cavities before endoluminal vacuum therapy (n = 5), and to remove foreign bodies from the upper gastrointestinal tract (n = 8). In these cases, the technical success rate was 100%. No moderate or severe/fatal complications were reported.
The over-the-scope-grasper is a promising device for endoscopic pancreatic necrosectomy, which is also appropriate for removing foreign bodies and blood clots, or cleaning insufficiency cavities prior to endoluminal vacuum therapy.
Prospective studies including more patients should be conducted to demonstrate the efficacy and clinical utility of the device.